13F
中

INFU INFUSYSTEM HOLDINGS INC

2026Q1 · CUSIP 45685K102 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
93
Δ holders QoQ
-6
Breadth percentile
Top 80%
Whale holders
45
Δ whales
+2
Inst. holding value
$129M
New positions
17
Closed positions
23
Price momentum (1Q)
+17.1%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+5 · h=31 2018Q2: Δ-3 · h=28 2018Q3: Δ+4 · h=32 2018Q4: Δ-2 · h=30 2019Q1: Δ+1 · h=31 2019Q2: Δ+1 · h=32 2019Q3: Δ+1 · h=33 2019Q4: Δ+14 · h=47 2020Q1: Δ+3 · h=50 2020Q2: Δ+14 · h=64 2020Q3: Δ+13 · h=77 2020Q4: Δ+10 · h=87 2021Q1: Δ+1 · h=88 2021Q2: Δ+1 · h=89 2021Q3: Δ-5 · h=84 2021Q4: Δ-4 · h=80 2022Q1: Δ-3 · h=77 2022Q2: Δ-9 · h=68 2022Q3: Δ-6 · h=62 2022Q4: Δ+2 · h=64 2023Q1: Δ+2 · h=66 2023Q2: Δ-2 · h=64 2023Q3: Δ+0 · h=64 2023Q4: Δ-1 · h=63 2024Q1: Δ+5 · h=68 2024Q2: Δ+11 · h=79 2024Q3: Δ+0 · h=79 2024Q4: Δ+7 · h=86 2025Q1: Δ+7 · h=93 2025Q2: Δ-1 · h=92 2025Q3: Δ+4 · h=96 2025Q4: Δ+3 · h=99 2026Q1: Δ-6 · h=93 2018Q1: holders=31 2018Q2: holders=28 2018Q3: holders=32 2018Q4: holders=30 2019Q1: holders=31 2019Q2: holders=32 2019Q3: holders=33 2019Q4: holders=47 2020Q1: holders=50 2020Q2: holders=64 2020Q3: holders=77 2020Q4: holders=87 2021Q1: holders=88 2021Q2: holders=89 2021Q3: holders=84 2021Q4: holders=80 2022Q1: holders=77 2022Q2: holders=68 2022Q3: holders=62 2022Q4: holders=64 2023Q1: holders=66 2023Q2: holders=64 2023Q3: holders=64 2023Q4: holders=63 2024Q1: holders=68 2024Q2: holders=79 2024Q3: holders=79 2024Q4: holders=86 2025Q1: holders=93 2025Q2: holders=92 2025Q3: holders=96 2025Q4: holders=99 2026Q1: holders=93 -14 -7 +0 +7 +14 2565104 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2020Q3 Top 19% +34.4% +41.0%
2020Q1 Top 19% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
25.1
EPS (TTM)
$0.37
EPS YoY
+146.7%
Revenue (TTM)
$0.1B
Revenue YoY
+3.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $27M 2022-09-30: $27M 2022-12-31: $29M 2023-03-31: $30M 2023-06-30: $32M 2023-09-30: $32M 2023-12-31: $32M 2024-03-31: $32M 2024-06-30: $34M 2024-09-30: $35M 2024-12-31: $34M 2025-03-31: $35M 2025-06-30: $36M 2025-09-30: $36M 2025-12-31: $36M 2026-03-31: $34M 2022-06-30: EPS -0.01 2022-09-30: EPS 0.02 2022-12-31: EPS 0.01 2023-03-31: EPS -0.02 2023-06-30: EPS 0.02 2023-09-30: EPS 0.03 2023-12-31: EPS 0.01 2024-03-31: EPS -0.05 2024-06-30: EPS 0.03 2024-09-30: EPS 0.08 2024-12-31: EPS 0.05 2025-03-31: EPS -0.01 2025-06-30: EPS 0.12 2025-09-30: EPS 0.11 2025-12-31: EPS 0.09 2026-03-31: EPS 0.05 0M 18M 36M $M -0.06 0.04 0.13 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 124 2023-06-30: PE 355.32023-09-30: PE 229.32023-12-31: PE 237.52024-03-31: PE 6442024-06-30: PE 327.52024-09-30: PE 123.72024-12-31: PE 73.82025-03-31: PE 412025-06-30: PE 40.12025-09-30: PE 35.22025-12-31: PE 24.32026-03-31: PE 23.7 21 349 676 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)